Corvus Pharma Com (NQ: CRVS )

4.300 USD -0.150 (-3.37%)

Official Closing Price Updated: 6:19 PM EDT, Sep 21, 2020 Add to My Watchlist

Price and Volume

Volume	194,802
Open	4.430
Bid (Size)	4.200 (1)
Ask (Size)	4.300 (3)
Prev. Close	4.450
Today's Range	4.200 - 4.550
52wk Range	1.010 - 6.880
Shares Outstanding	29,193,600
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

New Data from Ciforadenant Phase 1b/2 Clinical Study Presented at ESMO Virtual Congress 2020

September 17, 2020

Corvus Pharmaceuticals Appoints Edith Mitchell, M.D., to Board of Directors

September 11, 2020

Dr. Mitchell adds significant experience in cancer care, research and healthcare delivery as the Company advances pipeline into later-stage clinical development

Performance

YTD	-13.83%	-13.83%
1 Month	+11.11%	+11.11%
3 Month	+47.77%	+47.77%
6 Month	+111.82%	+111.82%
1 Year	+22.51%	+22.51%

More News

Corvus Pharmaceuticals Provides Update on Clinical Trial of CPI-006 for Patients with COVID-19

September 10, 2020

Corvus Announces Participation in Upcoming Investor Conferences

September 08, 2020

Corvus Pharmaceuticals to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference

August 04, 2020

Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2020 Financial Results

July 30, 2020

Corvus Pharmaceuticals to Provide Business Update and Report Second Quarter 2020 Financial Results on July 30, 2020

July 23, 2020

Unprecedented Collaboration Formed To Create Vaccine Against COVID-19

July 08, 2020

Unprecedented Collaboration Formed to Create Vaccine Against COVID-19

July 08, 2020

61 Biggest Movers From Yesterday

September 11, 2020

The Daily Biotech Pulse: Sanofi-GSK Land $2.1M Funding For Coronavirus Vaccine, D-Day For GW Pharma, FDA Nod For Roche

July 31, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.